Alector LLC

Nels P Nielson

Arnon Rosenthal

Seung-Joo Lee

Robert Pejchal

Tina Schwabe

Helen Lam

Patricia Culp

Ilaria Tassi

Philip Ling Kong

Eric Brown

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a TREM2 protein, e.g., a mammalian TREM2 or human TREM2, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-TREM2 antibodies and methods of use thereof

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-CD33 antibodies and methods of use thereof

Growing community of inventors

Hopkinton, NH, United States of America

Nels P Nielson